Skip to main content
SpringerLink
Log in
Book cover

Survivors of Childhood and Adolescent Cancer pp 109–123Cite as

Adverse Effects of Cancer Treatment of Hearing

  • Chapter

Part of the book series: Pediatric Oncology ((PEDIATRICO))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bates DE (2003) Aminoglycoside ototoxicity. Drugs Today (Barc) 39:277–285

    Article  Google Scholar 

  2. Bates DE, Beaumont SJ, Baylis BW (2002) Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother 36:446–451

    Article  PubMed  Google Scholar 

  3. Brock PR, Bellman SC, Yeomans EC et al. (1991) Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 19:295–300

    PubMed  Google Scholar 

  4. Brookhouser PE (2000) Diseases of the cochlea and labrynth. In:Wetmore RF, Muntz HR, McGill TJ (eds) Pediatric otolaryngology: principles and practice pathways. Thieme, New York, pp 327–354

    Google Scholar 

  5. Brookhouser PE, Beauchaine KL, Osberger MJ (1999) Management of the child with sensorineural hearing loss. Medical, surgical, hearing aids, cochlear implants. Pediatr Clin North Am 46:121–141

    PubMed  Google Scholar 

  6. Campbell KC, Durrant J (1993) Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am 26:903–914

    PubMed  Google Scholar 

  7. Cherow E, Dickman DM, Epstein S (1999) Organization resources for families of children with deafness or hearing loss. Pediatr Clin North Am 46:153–162

    Article  PubMed  Google Scholar 

  8. Chao WY, Leung HW (1995) Effects of irradiation on the rat middle ear mucosa. A scanning electron microscopic study. Eur Arch Otorhinolaryngol 252:244–248

    Article  PubMed  Google Scholar 

  9. Doolittle ND, Muldoon LL, Brummett RE et al. (2001) Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors. Clin Cancer Res 7:493–500

    PubMed  Google Scholar 

  10. Fee WE Jr (1980) Aminoglycoside ototoxicity in the human. Laryngoscope 90[Suppl 24]:1–19

    Google Scholar 

  11. Francis HW, Niparko JK (2003) Cochlear implantation update. Pediatr Clin North Am 50:341–346

    Article  PubMed  Google Scholar 

  12. Gamble JE, Peterson EA, Chandler JR (1968) Radiation effects on the inner ear. Arch Otolaryng 88:156–161

    PubMed  Google Scholar 

  13. Gratton MA, Salvi RJ, Kamen BA et al. (1990) Interaction of cisplatin and noise on the peripheral auditory system. Hear Res 50:211–223

    Article  PubMed  Google Scholar 

  14. Grau C, Moller K, Overgaard M et al. (1991) Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 21:723–728

    PubMed  Google Scholar 

  15. Hale GA, Marina NM, Jones-Wallace D et al. (1999) Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21:115–122

    Article  PubMed  Google Scholar 

  16. Hall JW (2000) Handbook of otoacoustic emissions. Singular, San Diego

    Google Scholar 

  17. Huang E, Teh BS, Strother DR et al. (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 52:599–605

    Article  PubMed  Google Scholar 

  18. Ilveskoski I, Saarinen UM, Wiklund T et al. (1996) Ototoxicity in children with malignant brain tumors treated with the “8 in 1” chemotherapy protocol. Med Pediatr Oncol 27:26–31

    Article  PubMed  Google Scholar 

  19. Kapoor G, Warrier RP, Shah SJ et al. (1996) Cisplatin and cranial irradiation related hearing loss in children. Proc ASCO 15:1436

    Google Scholar 

  20. Kemp G, Rose P, Lurain J et al. (1996) Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 14:2101–2112

    PubMed  Google Scholar 

  21. Landier W, Larson-Tuttle C (2004) Monitoring and management of ototoxicity. In: Altman AJ (ed) Supportive care of children with cancer: current therapy and guidelines from the children's oncology group, 3rd edn. Johns Hopkins University Press, Baltimore, pp 130–138

    Google Scholar 

  22. Lerner SA, Schmitt BA, Seligsohn R et al. (1986) Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 80:98–104

    Article  Google Scholar 

  23. Low WK, Fong KW (1998) Long-term post-irradiation middle ear effusion in nasopharyngeal carcinoma. Auris Nasus Larynx 25:319–321

    Article  PubMed  Google Scholar 

  24. Macdonald MR, Harrison RV, Wake M et al. (1994) Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children. J Otolaryngol 23:151–159

    PubMed  Google Scholar 

  25. Mann WJ, Maurer J, Marangos N (2002) Neural conservation in skull base surgery. Otolaryngol Clin North Am 35:411–424, ix

    Article  PubMed  Google Scholar 

  26. Marina N, Malogolowkin M, London WB et al. (2003) Amifostine does not protect against the Ototoxicity associated with high-dose cisplatin, etoposide and bleomycin (HD-PEB) in pediatric germ cell tumors (PGCT): a PGCT Intergroup Study. Proceedings of the American Society of Clinical Oncology, 31 May–3 June 2003, Chicago IL, p 798

    Google Scholar 

  27. Matz GJ (1993) Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am 26:705–712

    PubMed  Google Scholar 

  28. Merchant TE, Gould CJ, Xiong X et al. (2002) Early neurootologic effects of three-dimensional irradiation in children with primary brain tumors. 44th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), New Orleans, LA, 6–10 Oct 2002. Int J Radiat Oncology Biol Phys 54:201

    Article  Google Scholar 

  29. Meyer WH, Ayers D, McHaney VA et al. (1993) Ifosfamide and exacerbation of cisplatin-induced hearing loss. Lancet 341:754–755

    Article  Google Scholar 

  30. Neuwelt EA, Brummett RE, Doolittle ND (1998) First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 286:77–84

    PubMed  Google Scholar 

  31. Parsons SK, Neault MW, Lehmann LE et al. (1998) Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant 22:669–674

    Article  PubMed  Google Scholar 

  32. Peters U, Preisler-Adams S, Hebeisen A et al. (2000) Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs 11:639–643

    PubMed  Google Scholar 

  33. Riggs LC, Brummett RE, Guitjens SK et al. (1996) Ototoxicity resulting from combined administration of cisplatin and gentamicin. Laryngoscope 106:401–406

    Article  PubMed  Google Scholar 

  34. Roland JT, Cohen NL (1998) Vestibular and auditory ototoxicity. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE, Richardson MA (eds) Otolaryngology head and neck surgery, 3rd edn. Mosby, St Louis, pp 3186–3197

    Google Scholar 

  35. Rybak LP (1993) Ototoxicity of loop diuretics. Otolaryngol Clin North Am 26:829–844

    PubMed  Google Scholar 

  36. Schell MJ, McHaney VA, Green AA et al. (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 7:754–760

    PubMed  Google Scholar 

  37. Schweitzer VG (1993) Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 26:759–789

    PubMed  Google Scholar 

  38. Senan S, Rampling R, Graham MA et al. (1997) Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks. Clin Cancer Res 3:31–38

    PubMed  Google Scholar 

  39. Simon T, Hero B, Dupuis W et al. (2002) The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Padiatr 214:149–152

    Article  PubMed  Google Scholar 

  40. Sininger YS, Doyle KJ, Moore JK (1999) The case for early identification of hearing loss in children: auditory system development, experimental auditory deprivation, and development of speech perception and hearing. Pediatr Clin North Am 46:1–14

    Article  PubMed  Google Scholar 

  41. Smith CR, Lipsky JJ, Laskin OL et al. (1980) Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302:1106–1109

    PubMed  Google Scholar 

  42. Stach BA (1998) Clinical audiology: an introduction. San Diego, pp 208–209; 292–312

    Google Scholar 

  43. Stringer SP, Meyerhoff WL, Wright CG (1991) Ototoxicity. In: Paparella MM, Shumrick DA (eds) Otolaryngology, 3rd edn. Saunders, Philadelphia, pp.1653–1669

    Google Scholar 

  44. Takeno S, Harrison RV, Ibrahim D et al. (1994) Cochlear function after selective inner hair cell degeneration induced by carboplatin. Hear Res 75:93–102

    Article  PubMed  Google Scholar 

  45. Weatherly RA, Owens JJ, Catlin FI et al. (1991) Cis-platinum ototoxicity in children. Laryngoscope 101:917–924

    PubMed  Google Scholar 

  46. Young YH, Lu YC (2001) Mechanism of hearing loss in irradiated ears: a long-term longitudinal study. Ann Otol Rhinol Laryngol 110:904–906

    PubMed  Google Scholar 

Download references

Authors
  1. Wendy Landier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas E. Merchant
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Sidney Kimmel Cancer Center at Johns Hopkins, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD, 21287-5001, USA

    Cindy L. Schwartz

  2. Division of Oncology, Childrens Hospital of Philadelphia, 34th St. & Civic Ctr. Blvd., Philadelphia, PA, 19104, USA

    Wendy L. Hobbie

  3. Radiation Oncology and Pediatrics, University of Rochester Medical Center, 601 Elmwood Avenue, Box 647, Rochester, NY, 14642, USA

    Louis S. Constine

  4. Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA, 90027, USA

    Kathleen S. Ruccione

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Landier, W., Merchant, T.E. (2005). Adverse Effects of Cancer Treatment of Hearing. In: Schwartz, C.L., Hobbie, W.L., Constine, L.S., Ruccione, K.S. (eds) Survivors of Childhood and Adolescent Cancer. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26498-1_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-26498-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40840-6

  • Online ISBN: 978-3-540-26498-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation